Takeda Tells Jury Studies Tying Actos To Cancer Are Flawed
An attorney for Takeda Pharmaceutical Co. Ltd. on Friday told jurors that two men who developed bladder cancer after taking the company's diabetes drug Actos rely on second-rate science in their...To view the full article, register now.
Already a subscriber? Click here to view full article